BIOMAT Database Logo BIOMAT Database Logo

The treatment of lymphomas with vincaleukoblastine and methylhydrazine. 1968

E Anlesio, and A Calciati, and V Caramello

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine

Related Publications

E Anlesio, and A Calciati, and V Caramello
[Treatment of Hodgkin's disease with vincaleukoblastine and methylhydrazine. (Preliminary note)].
January 1966, Studii si cercetari de medicina interna,
E Anlesio, and A Calciati, and V Caramello
[Therapy of lymphomas with a methylhydrazine derivative].
August 1967, Prensa medica argentina,
E Anlesio, and A Calciati, and V Caramello
[MORPHOLOGICAL AND ENZYMO-CHEMICAL EXAMINATIONS WITH VINCALEUKOBLASTINE ON ASCITIC LYMPHOMAS].
January 1963, Bulletin de l'Association francaise pour l'etude du cancer,
E Anlesio, and A Calciati, and V Caramello
[Treatment of lymphomas with a derivative of methylhydrazine (Ro 4-6467). Clinical study on 34 cases].
January 1967, Sangre,
E Anlesio, and A Calciati, and V Caramello
[Trial of treatment of Hodgkin's disease and other lymphomas with a methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride].
March 1965, Revista medica del Hospital General,
E Anlesio, and A Calciati, and V Caramello
Vincaleukoblastine in the treatment of malignant disease.
September 1961, Canadian Medical Association journal,
E Anlesio, and A Calciati, and V Caramello
[Vincaleukoblastine in the treatment of malignant hemopathies].
February 1964, Semaine therapeutique,
E Anlesio, and A Calciati, and V Caramello
[Immunoglobulins and treatment with an immunosuppressive agent: methylhydrazine].
April 1969, Bollettino della Societa italiana di biologia sperimentale,
E Anlesio, and A Calciati, and V Caramello
[Treatment of Kaposi's angiosarcomatosis by vincaleukoblastine].
January 1968, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
E Anlesio, and A Calciati, and V Caramello
[Treatment of Kaposi's angiosarcomatosis by vincaleukoblastine].
December 1968, Lyon medical,
Copied contents to your clipboard!